Nooruddin Shaik. “A Critical Review of Cinqair (Reslizumab) in the Treatment of Severe Asthma Patients”. Future Journal of Pharmaceuticals and Health Sciences, vol. 3, no. 2, May 2023, pp. 126–133, doi:10.26452/fjphs.v3i2.442.